No products in the basket.
Genetic Prostate Cancer Risk Test
£689.00
Take control of your future health with the Genetic Prostate Cancer Risk Test—a precision screening tool that analyses inherited genetic variants linked to an increased risk of prostate cancer.
With growing evidence supporting the role of genetics in cancer risk, this test helps individuals understand their unique predisposition so they can take proactive, personalised steps to protect their long-term wellbeing.
RESULTS WITHIN
2 to 5 working days
Why get tested
While lifestyle and environment play key roles in cancer development, hereditary prostate cancer accounts for approximately 5–10% of cases. If you have a family history of prostate, breast, ovarian, or pancreatic cancers—especially with early onset or affecting multiple relatives—you may be at increased genetic risk.
By understanding your genetic profile, you and your healthcare provider can:
- Monitor more closely for early warning signs.
- Make personalised decisions about screening frequency and methods.
- Consider risk-reducing strategies or referral to genetic counselling.
- Inform family members who may also be at risk.
Genetic insights empower proactive health—not just for you, but for your entire family tree.
What we test
Take control of your future health with the Genetic Prostate Cancer Risk Test—a precision screening tool that analyses inherited genetic variants linked to an increased risk of prostate cancer.
With growing evidence supporting the role of genetics in cancer risk, this test helps individuals understand their unique predisposition so they can take proactive, personalised steps to protect their long-term wellbeing.
🧪 What’s Analysed:
This test screens for pathogenic or likely pathogenic variants across a panel of high-impact genes associated with hereditary prostate cancer and other related cancer syndromes:
| Gene | Role in Cancer Risk |
|---|---|
| ATM | DNA damage repair; mutations increase prostate cancer risk. |
| BRCA1 | Typically associated with breast/ovarian cancer, but also linked to early-onset prostate cancer. |
| BRCA2 | Strongly associated with hereditary prostate and breast cancers. |
| CHEK2 | Cell cycle control gene; variants may elevate risk of prostate and other cancers. |
| EPCAM | Associated with Lynch syndrome through MSH2 gene silencing. |
| HOXB13 | Specific mutations (e.g. G84E) are linked to early-onset familial prostate cancer. |
| MLH1, MSH2, MSH6, PMS2 | DNA mismatch repair genes associated with Lynch syndrome and increased prostate cancer susceptibility. |
| NBN | Involved in DNA repair; variants may increase prostate cancer risk. |
| PALB2 | Works with BRCA2; mutations may raise prostate and breast cancer risk. |
| RAD51D | Rare variants linked to prostate and ovarian cancers. |
| TP53 | Tumor suppressor gene; associated with Li-Fraumeni syndrome and multiple early-onset cancers. |
FAQ
How long will the appointment last?
The appointment will usually about 15 minutes. Do not hesitate to contact us if you have any question about your appointment.
What happens during the appointment?
This is dependent on the type of test. It usually involves a blood draw, body measurements.
How do I prepare for my appointment?
Please do not consume food or drink for at least 8 hours prior to the appointment. This excludes water, please stay well hydrated. Please do not chew gum.
Non fasting can impact the following; heart health, cardiovascular risk score, diabetes health, iron status or testosterone levels (males).
Do not smoke for a minimum of 30 minutes before your appointment.
Please avoid strenuous exercise for 48 hours before your appointment.
You may receive additional Information after booking to provide guidance.
What happens after my appointment?
Your samples will be sent to the lab for analysis and within 2-5 business days you will receive notification to access your blood test results or receive an email. If you have opted for a health and wellbeing discussion one of our personal co-ordinators will then be in touch to arrange a consultation call with a scientific advisor.